JPRN-UMIN000003168招募中4 期
Clinical research on concurrent therapy of Ezetimibe and Statin - Absorption control Concurrent Therapy study(ACT study)
Tokushima Red Cross Hospital0 个研究点目标入组 200 人开始时间: 2010年2月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patient that there is previous history of hypersensitivity in experimental drug or Statin (2)TG 400mg/dL or more (When the measurement of LDL-C is only a calculation method) (3)Patients with hepatic dysfunction (ALT>3 x upper limit of normal range) (4)Patients with renal dysfunction (Serum creatinine >2 x upper limit of normal range) (5)Patient of 9% or more in HbA1c (6)Patient of 1% or more in change of HbA1c (7)Patients with secondary hyperlipidemia or medicinal hyperlipemia (8)Patients with a history of CABG operation or stroke within recent 3 months (9)Pregnant or possibly pregnant women (10)Patients who are judged to be inappropriate as a subject by a doctor
研究者
相似试验
已完成
不适用
Combination therapy with Ezetimibe and Gemfibrozile on post-prandial hypertriglyceridemiaDiabetes.Non-insulin-dependent diabetes mellitusIRCT201105311179N5Zanjan Metabolic Research Center, Zanjan University of medical science90
招募中
不适用
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048
已完成
不适用
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolismhypercholesterolemiaJPRN-UMIN000004183Hiroshima University hospital Department of General Medicine60
已完成
不适用
Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000001071Osaka City University Graduate School of Medicine60
未知
4 期
Effect of ezetimibe/statin combination therapy in patients with type 2 diabetes and dyslipidemia on remnant and inflammatioJPRN-UMIN000002318Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology100